American Association for the Advancement of Science, Science Translational Medicine, 570(12), 2020
DOI: 10.1126/scitranslmed.abd3876
Full text: Unavailable
Some patients with severe COVID-19 develop prothrombotic autoantibodies that are similar to antiphospholipid antibodies found in autoimmune diseases.